• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺表面活性剂纳米粒作为胰岛素干粉递药吸收促进剂的制备与应用。

The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.

机构信息

Department of Pharmacy, China Pharmaceutical University, Nanjing, PR China.

出版信息

Drug Dev Ind Pharm. 2009 Sep;35(9):1059-65. doi: 10.1080/03639040902769628.

DOI:10.1080/03639040902769628
PMID:19640250
Abstract

AIM

To study the preparation and application of pulmonary surfactant (PS) nanoparticles as absorption enhancers in insulin dry powder delivery. PS is a complex mixture of mainly phospholipids and proteins. The composition leads to a unique spreading effect of the surfactants as well as spontaneous nanoparticles formation, which may be favorable characteristics of pulmonary drug delivery systems.

METHOD

In this article, insulin has been a model drug, as an important drug in lowering blood glucose and as a classic protein drug. PS was extracted from pig lungs and was observed as nanoparticles morphology in water by transmission electron microscopy after preparation. Inhalation dry powders were formulated by PS nanoparticles, insulin, and other excipients. In addition, blood glucose level of rats was determined when the insulin dry powder of PS group and control group was delivered by inhalation route.

RESULT

Compared with control group, scanning electron microscopy showed that the dry powders of PS group possess similar particle size and smoother surface. The spray-dried powders re-suspended possessed similar nanoparticle appearance compared with the original PS suspension. Animal studies showed that blood glucose level was effectively reduced when the insulin dry powder of PS group was delivered by inhalation route. Compared with subcutaneous injection group (4 U/kg), the relative pharmacological bioavailability of the insulin dry powders of control group (14 U/kg) and PS group (14 U/kg) was 19.97% and 32.57%, respectively.

CONCLUSION

PS nanoparticles, as absorption enhancers used in dry powder inhalation, could evidently enhance the effect of insulin in lowering blood glucose.

摘要

目的

研究肺表面活性剂(PS)纳米颗粒作为胰岛素干粉递药吸收促进剂的制备和应用。PS 是一种主要由磷脂和蛋白质组成的复杂混合物。这种组成导致了表面活性剂独特的铺展效果和自发形成纳米颗粒,这可能是肺部药物传递系统的有利特征。

方法

本文以胰岛素为模型药物,作为降低血糖的重要药物和经典蛋白药物。PS 从猪肺中提取,经制备后在水中用透射电子显微镜观察到纳米颗粒形态。通过 PS 纳米颗粒、胰岛素和其他赋形剂来配制吸入干粉。此外,当 PS 组和对照组的胰岛素干粉通过吸入途径给药时,测定大鼠的血糖水平。

结果

与对照组相比,扫描电子显微镜显示 PS 组的干粉具有相似的粒径和更光滑的表面。喷雾干燥粉末再混悬后与原始 PS 悬浮液具有相似的纳米颗粒外观。动物研究表明,当 PS 组的胰岛素干粉通过吸入途径给药时,血糖水平得到有效降低。与皮下注射组(4U/kg)相比,对照组(14U/kg)和 PS 组(14U/kg)的胰岛素干粉的相对药理生物利用度分别为 19.97%和 32.57%。

结论

作为干粉吸入用吸收促进剂的 PS 纳米颗粒,可显著增强胰岛素降低血糖的效果。

相似文献

1
The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.肺表面活性剂纳米粒作为胰岛素干粉递药吸收促进剂的制备与应用。
Drug Dev Ind Pharm. 2009 Sep;35(9):1059-65. doi: 10.1080/03639040902769628.
2
Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.喷雾干燥法制备的吸入用胰岛素干粉的物理特性和气雾化性能
J Pharm Pharmacol. 2007 Jul;59(7):927-34. doi: 10.1211/jpp.59.7.0003.
3
Hypoglycemic efficacy of pulmonary delivered insulin dry powder aerosol in rats.肺部给药胰岛素干粉气雾剂对大鼠的降血糖疗效。
Acta Pharmacol Sin. 2002 May;23(5):467-70.
4
Insulin-micro- and nanoparticles for pulmonary delivery.用于肺部给药的胰岛素微纳米颗粒。
Int J Pharm. 2009 Jul 30;377(1-2):173-9. doi: 10.1016/j.ijpharm.2009.05.008. Epub 2009 May 14.
5
Deposition of insulin powders for inhalation in vitro and pharmacodynamic evaluation of absorption promoters in rats.
Yao Xue Xue Bao. 2005 Dec;40(12):1069-74.
6
Novel dry powder inhaler formulation of glucagon with addition of citric acid for enhanced pulmonary delivery.含有柠檬酸的新型胰高血糖素干粉吸入剂配方,可增强肺部递送。
Int J Pharm. 2009 Dec 1;382(1-2):144-50. doi: 10.1016/j.ijpharm.2009.08.024. Epub 2009 Aug 22.
7
Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.壳聚糖纳米微球用于肺部蛋白递药:载胰岛素制剂的体内评价。
J Control Release. 2012 Feb 10;157(3):383-90. doi: 10.1016/j.jconrel.2011.08.008. Epub 2011 Aug 12.
8
Microencapsulated chitosan nanoparticles for lung protein delivery.用于肺部蛋白质递送的微囊化壳聚糖纳米颗粒。
Eur J Pharm Sci. 2005 Jul-Aug;25(4-5):427-37. doi: 10.1016/j.ejps.2005.04.009.
9
Fabrication of inhalable spore like pharmaceutical particles for deep lung deposition.可吸入孢子状药物颗粒的制备及其在肺部的深层沉积。
Int J Pharm. 2012 Jul 1;430(1-2):98-103. doi: 10.1016/j.ijpharm.2012.03.044. Epub 2012 Apr 1.
10
Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.微囊化方法和肽负载对聚(丙交酯-乙交酯)胰岛素纳米粒制剂的影响。
Pharmazie. 2006 Jul;61(7):613-7.

引用本文的文献

1
Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.植物细胞包封的人用生物制药、自身抗原和疫苗抗原的口服递送。
Adv Drug Deliv Rev. 2013 Jun 15;65(6):782-99. doi: 10.1016/j.addr.2012.10.005. Epub 2012 Oct 23.